| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61aae61dd1bddf33f412527a85b86fe5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 |
| filingDate |
2003-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c032a23175a39baf1851ebe73292842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4f226071ff85f81837ae2a4d58b6935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_491523a5793dc3108af535a655bb05b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0142d60db6b50fa8efb71280b67cbcec |
| publicationDate |
2004-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1469840-A1 |
| titleOfInvention |
Cyclosporin-containing sustained release pharmaceutical composition |
| abstract |
The present invention relates to a cyclosporin-containing sustained release pharmaceutical composition. More particularly, the present invention is directed to a cyclosporin-containing sustained release pharmaceutical composition essentially comprising a biodegradable polymer, cyclosporin and a release modifier encapsulated therein, in which cyclosporin and the release modifier are encapsulated in the biodegradable polymer and the release modifier is at least one member selected from the group consisting of hydrophilic release modifiers and lipophilic release modifiers. |
| priorityDate |
2002-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |